11,357 followers
Un nuevo antígeno multietapa ERA005f confiere protección contra Mycobacterium tuberculosis al impulsar respuestas inmunes de células T de tipo Th-1 y Th-17. https://t.co/uMyrfy3STM
Un nuevo antígeno multietapa ERA005f confiere protección contra Mycobacterium tuberculosis al impulsar respuestas inmunes de células T de tipo Th-1 y Th-17. https://t.co/uMyrfy3STM
RT @FrontImmunol: New Research: A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 an…
New Research: A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 and Th-17 type T cell immune responses: Introduction Tuberculosis (TB) is a major threat to human health. In 2021, TB was… https://t.co/